Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

BackgroundChemotherapy is the standard adjuvant treatment for colon cancer. Chinese herbal formula PRM1201 improves the efficacy of chemotherapy when used in combination with Cetuximab or Bevacizumab in patients with metastatic colorectal cancer. This study aims to explore the benefits of treatment...

Full description

Bibliographic Details
Main Authors: Ru Jia, Ningning Liu, Guoxiang Cai, Yun Zhang, Haijuan Xiao, Lihong Zhou, Qing Ji, Ling Zhao, Puhua Zeng, Huaimin Liu, Jiege Huo, Xiaoqiang Yue, Yi Zhang, Chaojun Wu, Xiaoting Sun, Yuanyuan Feng, Hongjie Liu, Hui Liu, Zhifen Han, Youying Lai, Yanbo Zhang, Gang Han, Hangjun Gong, Yan Wang, Qi Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
colon cancer
Chinese herbal medicine
cancer recurrence and metastasis
disease-free survival
clinical trial
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.618793/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.618793/full

Similar Items